Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arian Laurence

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
The Open Rheumatology Journal|October 3, 2012
JAK Kinases in Health and Disease: An UpdateArian Laurence, Marko Pesu, Olli Silvennoinen, et al.
F1000 Medicine Reports|March 10, 2012
Kinase inhibitors in the treatment of immune-mediated diseaseApostolos Kontzias, Arian Laurence, Massimo Gadina, et al.
Current Opinion in Immunology|April 14, 2009
The Current STATus of lymphocyte signaling: new roles for old playersAdewole S Adamson, Kalonji Collins, Arian Laurence, et al.
European Journal of Immunology|February 10, 2004
Identification of pro-interleukin 16 as a novel target of MAP kinases in activated T lymphocytesArian Laurence, Emmanuelle Astoul, Sarah Hanrahan, et al.
The Journal of Biological Chemistry|September 22, 2007
IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent mannerLai Wei, Arian Laurence, Kevin M Elias, et al.
Current Opinion in Pharmacology|July 24, 2012
Jakinibs: a new class of kinase inhibitors in cancer and autoimmune diseaseApostolos Kontzias, Alexander Kotlyar, Arian Laurence, et al.
Nature Reviews. Immunology|March 26, 2011
Genomic views of STAT function in CD4+ T helper cell differentiationJohn J O'Shea, Riitta Lahesmaa, Golnaz Vahedi, et al.
Annals of the Rheumatic Diseases|March 28, 2013
Janus kinase inhibitors in autoimmune diseasesJohn J O'Shea, Apostolos Kontzias, Kunihiro Yamaoka, et al.
Trends in Immunology|July 26, 2011
T helper 17 cell heterogeneity and pathogenicity in autoimmune diseaseKamran Ghoreschi, Arian Laurence, Xiang-Ping Yang, et al.
Arthritis and Rheumatism|September 1, 2007
Distinct regulation of interleukin-17 in human T helper lymphocytesZhi Chen, Cristina M Tato, Linda Muul, et al.
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
The Open Rheumatology Journal|October 3, 2012
JAK Kinases in Health and Disease: An UpdateArian Laurence, Marko Pesu, Olli Silvennoinen, et al.
F1000 Medicine Reports|March 10, 2012
Kinase inhibitors in the treatment of immune-mediated diseaseApostolos Kontzias, Arian Laurence, Massimo Gadina, et al.
Current Opinion in Immunology|April 14, 2009
The Current STATus of lymphocyte signaling: new roles for old playersAdewole S Adamson, Kalonji Collins, Arian Laurence, et al.
European Journal of Immunology|February 10, 2004
Identification of pro-interleukin 16 as a novel target of MAP kinases in activated T lymphocytesArian Laurence, Emmanuelle Astoul, Sarah Hanrahan, et al.
The Journal of Biological Chemistry|September 22, 2007
IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent mannerLai Wei, Arian Laurence, Kevin M Elias, et al.
Current Opinion in Pharmacology|July 24, 2012
Jakinibs: a new class of kinase inhibitors in cancer and autoimmune diseaseApostolos Kontzias, Alexander Kotlyar, Arian Laurence, et al.
Nature Reviews. Immunology|March 26, 2011
Genomic views of STAT function in CD4+ T helper cell differentiationJohn J O'Shea, Riitta Lahesmaa, Golnaz Vahedi, et al.
Annals of the Rheumatic Diseases|March 28, 2013
Janus kinase inhibitors in autoimmune diseasesJohn J O'Shea, Apostolos Kontzias, Kunihiro Yamaoka, et al.
Trends in Immunology|July 26, 2011
T helper 17 cell heterogeneity and pathogenicity in autoimmune diseaseKamran Ghoreschi, Arian Laurence, Xiang-Ping Yang, et al.
Arthritis and Rheumatism|September 1, 2007
Distinct regulation of interleukin-17 in human T helper lymphocytesZhi Chen, Cristina M Tato, Linda Muul, et al.
Pageof 11